Cardiac thrombosis, a serious medical condition, refers to the formation of blood clots within the heart's chambers or blood vessels. This phenomenon poses a significant threat to cardiovascular health, as these clots can obstruct blood flow, leading to potentially life-threatening complications such as heart attacks or strokes. The development of cardiac thrombosis is often associated with underlying cardiovascular diseases, such as atrial fibrillation, myocardial infarction, or heart valve disorders. Additionally, individuals with certain risk factors, including obesity, smoking, and a sedentary lifestyle, may be more susceptible to this condition. Timely diagnosis and intervention are crucial in managing cardiac thrombosis. Treatment may involve anticoagulant medications to prevent further clot formation and reduce the risk of adverse events. Patients are typically closely monitored by healthcare professionals to ensure an effective and personalized management plan, emphasizing the importance of lifestyle modifications and ongoing medical care to mitigate the risk of recurrence.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation